- Home
- AVBH vs AVTX Comparison
AVBH vs AVTX Comparison
Compare AVBH & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$17.00
Company Overview
Basic Information| Metric | AVBH | AVTX |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.4M | 339.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | AVBH | AVTX |
|---|---|---|
| Price | $27.43 | $17.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $33.00 | $32.57 |
| AVG Volume (30 Days) | 68.7K | ★ 510.9K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.66 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | $360.39 | N/A |
| Revenue Next Year | $11.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $22.95 | $3.39 |
| 52 Week High | $31.61 | $20.72 |
Technical Indicators
Market Signals| Indicator | AVBH | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.44 | 53.15 |
| Support Level | $26.93 | $15.36 |
| Resistance Level | $27.72 | $19.26 |
| Average True Range (ATR) | 0.79 | 1.36 |
| MACD | -0.30 | 0.06 |
| Stochastic Oscillator | 0.95 | 62.06 |
Price Performance
Historical Comparison AVBH
AVTX
About AVBH Avidbank Holdings Inc.
Avidbank Holdings Inc is a full-service commercial bank. It offers various services such as commercial and industrial lending, venture lending, structured finance, asset-based lending, sponsor finance, real estate construction, and commercial real estate lending.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).